tiprankstipranks
Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
US Market
APGE
Apogee Therapeutics
RESEARCH TOOLSreports

Apogee Therapeutics (APGE) Income Statement

Compare
360 Followers

Apogee Therapeutics Income Statement

Last quarter (Q4 2025), Apogee Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Apogee Therapeutics's net income was $-69.39M. See Apogee Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.42M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 284.18M$ 216.87M$ 93.00M$ 30.73M
Depreciation and Amortization
$ 1.42M$ 189.00K$ 9.02M$ 0.00
EBITDA
$ -284.18M$ -216.68M$ -74.97M$ -39.78M
Operating Income
$ -285.60M$ -216.87M$ -93.00M$ -30.73M
Other Income/Expenses
$ 30.03M$ 34.74M$ 9.02M$ -9.06M
Pretax Income
$ -255.56M$ -182.13M$ -83.98M$ -39.78M
Net Income
$ -255.84M$ -182.15M$ -83.98M$ -39.78M
Per Share Metrics
Basic EPS
$ -4.22$ -3.30$ -1.66$ -0.79
Diluted EPS
$ -4.22$ -3.30$ -1.66$ -0.79
Weighted Average Shares Outstanding
 60.69M 55.19M 50.66M 50.67M
Weighted Average Shares Outstanding (Diluted)
 60.69M 55.19M 50.66M 50.67M
Currency in USD

Apogee Therapeutics Earnings and Revenue History